Drug Type Interferons, Biosimilar |
Synonyms- |
Target |
Action agonists, modulators, inducers |
Mechanism IFNAR agonists(Interferon alpha/beta receptor agonists), Immunomodulators, Innate antiviral immune response inducers |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingClinical |
First Approval Date- |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hairy Cell Leukemia | Clinical | - | - | |
Hepatitis C | Clinical | - | - | |
Kaposi Sarcoma | Clinical | - | - | |
Philadelphia chromosome positive chronic myelogenous leukemia | Clinical | - | - |